45
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Ketoconazole in Cushing's disease: is it worth a try?

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The use of ketoconazole has been recently questioned after warnings from the European Medicine Agencies and the Food and Drug Administration due to potential hepatotoxicity. However, ketoconazole is frequently used as a drug to lower circulating cortisol levels. Several pharmacological agents have recently been approved for the treatment of Cushing's disease (CD) despite limited efficacy or significant side effects. Ketoconazole has been used worldwide for more than 30 years in CD, but in the absence of a large-scale study, its efficacy and tolerance are still under debate.

          Related collections

          Author and article information

          Journal
          J Clin Endocrinol Metab
          The Journal of clinical endocrinology and metabolism
          The Endocrine Society
          1945-7197
          0021-972X
          May 2014
          : 99
          : 5
          Affiliations
          [1 ] Aix Marseille Université, Hopital de la Timone (F.C., M.P., I.M., B.C.-D., T.B.), Service d'Endocrinologie, 13005, Marseille, France; Hôpital Cochin Service d'Endocrinologie et Maladies Métaboliques (L.G., L.Q., C.B., J.B.), 75014, Paris, France; Centre Hospitalier Universitaire (CHU) de Bordeaux Hôpital du Haut Lévêque Service d'Endocrinologie-Diabétologie et Maladies Métaboliques (P.G., A.T.), 33600 Pessac, France; CHU de Grenoble Hôpital Albert Michallon Service d'Endocrinologie-Diabétologie-Nutrition (M.Mu., M.Ma., O.C.), 38043, Grenoble, France; Université Paris-Sud Service d'Endocrinologie et Maladies de la Reproduction (P.K., P.Ch., J.Y.), 94270, Le Kremlin Bicetre, France; CHU de Nantes Hôpital G & R Laënnec St-Herblain Endocrinologie, Maladies Métaboliques et Nutrition (D.D., M.L.B.), 44093, Nantes, France; Hôpital Larrey Service d'Endocrinologie-Maladies Métaboliques-Nutrition (P.Ca., D.V.), 31400, Toulouse, France; CHU de Strasbourg Hôpital de Hautepierre (F.L., B.G.), Service de Médecine Interne et de Nutrition, 67100 Strasbourg, France; Assistance Publique-Hôpitaux de Paris, Hôpital St-Antoine Service d'Endocrinologie-Diabétologie et Médecine de la Reproduction (B.Do., S.C.-M.), 75012, Paris, France; Centre Hospitalier Regional Universitaire de Lille Hôpital Claude Huriez, Service d'Endocrinologie Métabolisme (M.C.V.), 59000 Lille, France; Hôpital Avicenne Service d'Endocrinologie, Diabétologie, et Maladies Métaboliques (H.B.), 93000 Bobigny, France; CHU de Reims Hôpital Robert Debré (B.De.), Service d'Endocrinologie-Diabète-Nutrition, 51092, Reims, France; Hôpital Neuro-cardiologique Fédération d'Endocrinologie du Pôle Est (G.R.), 39500 Bron, France; and Hôpital de Bicêtre Endocrinologie Pédiatrique (E.M.), 94270, Le Kremlin Bicetre, France.
          Article
          10.1210/jc.2013-3628
          24471573
          8507f039-99f4-4a61-9a63-0382f11b7d35
          History

          Comments

          Comment on this article

          scite_
          266
          4
          239
          0
          Smart Citations
          266
          4
          239
          0
          Citing PublicationsSupportingMentioningContrasting
          View Citations

          See how this article has been cited at scite.ai

          scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

          Similar content416

          Cited by99